2011 業績紹介

2011年

1. 成人および高齢者の精神・神経疾患の認知神経科学的研究

－論文－

  1. *Kishi T, Kitajima T, Tsunoka T, Okumura T, Okuchi T, Kawashima K, Okochi T, Yamanouchi Y, Kinoshita Y, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N: Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence. Curr Neuropharmacol 2011;9(1):133-136.
  2. *Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, Sora I:Association analysis of the adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis. Curr Neuropharmacol 2011;9(1):137-142.
  3. *Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, Sora I:Association analysis of the tryptophan hydroxylase 2 gene polymorphisms in patients with methamphetamine dependence/psychosis. Curr Neuropharmacol 2011;9(1):176-182.
  4. *Okahisa Y, Kotaka T, Takaki M, Inada T, Uchimura N, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, Ujike H: Association between the regulator of G-protein signaling 9 gene and patients with methamphetamine use disorder and schizophrenia. Curr Neuropharmacol 2011;9(1):190-194.
  5. *Uchiyama M, Inoue Y, Uchimura N, Kawamori R, Kurabayashi M, Kario K, Watada H: Clinical significance and management of insomnia. Sleep Biol Rhythms 2011;9(2):63-72.
  6. *Yoshimura T, Usui H, Takahashi N, Yoshimi A, Saito S, Aleksic B, Ujike H, Inada T, Yamada M, Uchimura N, Iwata N,Sora I, Iyo M, Ozaki N: Association analysis of the GDNF gene with methamphetamine use disorder in a Japanise population. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(5):1268-1272.
  7. *Kishi T, Okochi T, Kitajima T, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Correll C.U, Iwata N: Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(7):1618-1622.
  8. *Kishi T, Fukuo Y, Okochi T,Kitajima T,Kawashima K, Naitoh H,Ujike, H,Inada T, Yamada M,Uchimura N, Sora I, Iyo M, Ozaki N,Iwata N:Serotonin 6 reveptor gene is associated with methamphe tamine-induced psychosis in a Japanese population. Drug Alcohol Depend 2011;113(1):1-7.
  9. *Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N:Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Med 2011;12:119-126.
  10. *Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimra N:Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep Med 2011;12:127-133.
  11. *Uchimura N, Ogawa A, Hamamura M, Hashimoto T, Nagata H, Uchiyama M:Efficacy and safety of ramelteon in Japanese adults with chronic insomnia:a randomized, double-blind, placebo-controlled study.Expert Rev Neurother 2011;11(2):215-224.
  12. *Kawabe C,Morita K,Shoji Y,Fujiki R,Yamamoto A,Asaumi Y,Uchimura N: Effects of emotionally affect Adult and Baby' Photographs in healthy controls and schizophrenic patients evaluating by exploratory eye movements. Kurume Med J 2011;58:27-33.
  13. *Abe T, Hagiwara N, Hirohata M, Uchiyama Y, Tanaka N, Hayabuchi N: Partially thrombosed vertebral artery aneurysm with wall enhancement treated by stent-assisted coil embolization. Neurol Med Chir (Tokyo) 2011;51(6):431-433.
  14. *Tsuchimoto R, Kanba S, Hirano S, Oribe N, Ueno T, Hirano Y, Nakamura I, Oda Y, Miura T, Onitsuka T：Reduced high and low frequency gamma synchronization in patients with chronic schizophrenia. Schizophrenia Res 2011;133:99-105.
  15. Ueno T, Hirano S, Hirano Y, Oribe N, Nakamura I, Oda Y, Kanba S, Onitsuka T: Stability of the Rayleigh distribution. Proc International Cong Imaging Signal Processing IEEE 2011;5:2402-2403.
  16. Shimo K,Ueno T,J YoungerNishihara M, Inoue S,Ikemoto T,Taniguchi S,Ushida T : Visualization of Painful Experiences Believed to Trigger the Activation of Affective and Emotional Brain Regions in Subjects with Low Back Pain. PLoS ONE 2011;6(11):e26681.
  17. *Ogawa, S K, Tanaka E, Shin M C, Kotani N, Akaike N: Volatile anesthetic effects on isolated GABA synapses and extrasynaptic receptors. Neuropharmacology 2011;60: 701-710.
  18. *Okamura H, Tsuda A, Matsuishi T: The relationship between perceived loneliness and cortisol awakening responses on work days and weekends. Japanese Psychological Research 2011;53(2):113-120.
  19. *Gothelf D, Hoeft F, Ueno T, Sugiura L, Lee AD, Thompson P, Reiss AL: Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome. J Psychiatr Res 2011;45(3):322-331.

2. 成人および高齢者の精神・神経疾患の分子生物学的研究

－総説－

  1. *Nishi A, Kuroiwa M, Shuto T : Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons. Front Neuroanat 2011;5:43.
  2. *Shuto T, Nishi A : Treatment of the psychostimulant-sensitized animal model of schizophrenia. CNS Neurosci Ther 2011 Apr;17(2):133-139.
  3. Kikuchi K, Kawahara K, Miura N, Ito T, Morimoto Y, Tancharoen S, Takeshige N, Uchikado H, Sakamoto R, Miyagi N, Kikuchi C, Iida N, Shiomi N, Kuramoto T, Hirohata M, Maruyama I, Morioka M, Tanaka E : Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy (Review). Exp Ther Med 2012;4:3-7.
  4. *Nishi Y, Yoh J, Hiejima H and Kojima M.: Structures and molecular forms of ghrelin family peptides.　Peptides (an International Journal) 2011;32(11):2175-2182.
    5. Koga Y, Mishima Y, Hara M, Hiraki T, Ushijima K：Prognostic factors associated with mortality in patients undergoing emergency surgery for abdominal aortic aneurysms. J Anesth 2011;6(25):666-671.

－論文－

  1. *Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, Ushikubi F, Kitaoka S, Aoki T, Inoue H, Matsuoka T, Narumiya S: Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake. Eur J Neurosci 2011 Aug;34(4):594-604.
  2. *Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M: Fukuoka Kinki Parkinson's Disease Study Group (contributor: Taniwaki T): Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci 2011;306:98-102.
  3. *Fotovati A, Abu-Ali S, Sugita Y, Nakamura Y: Expression of N-myc downstream regulated gene 1(NDRG1) in central neurocytoma. J Clin Neurosci 2011;18:1383-1385.
  4. *Yamashita S, Hasuo H, Tokutomi T, Shigemori M, Akasu T: Edaravone attenuates impairment of synaptic plasticity in granule cell layer of the dentate gyrus following traumatic brain injury. Kurume Med J 2011;58(2):47-58.
  5. *Okamura H, Tsuda A, Matsuishi T: The relationship between perceived loneliness and cortisol awakening responses on work days and weekends. Japanese Psychological Research 2011;53:113-120.
  6. *Horiuchi S, Tsuda A, Kobayashi H, Prochaska JM: Reliability and validity of the Japanese language version of Pro-Change's decisional balance measure for effective stress management. Japanese Psychological Research 2011;54:128-136.
  7. *Shuto T, Nishi A: Treatment of the psychostimulant-sensitized animal model of schizophrenia. CNS Neurosci Ther 2011;17(2):133-139.
  8. *Terasaki M, Eto T, Nakashima S, Okada Y, Ogo E, Sugita Y, Tokutomi T, Shigemori M: A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. J Neurooncol 2011;102(2):247-253.
  9. *Miura S, Shibata H, Kida H, Noda K, Toyama T, Iwasaki N, Iwaki A, Ayabe M, Aizawa H, Taniwaki T, Fukumaki Y: Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family. Neurogenetics 2011;12(1):25-31.
  10. *Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group(Collaborators; Taniwaki T): Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: A case-control study in Japan. Parkinsonism Relat Disord 2011;17(2):112-116.
  11. *Yoh J, Nishi Y, Hosoda H, Tajiri Y, Yamada K, Yanase T, Doi R, Yonemoto K, Kangawa K, Kojima M, Tanaka E, Kusukawa J: Plasma levels of n-decanoyl ghrelin, another acyl- and active form of ghrelin, in human subjects, and the effect of glucose- or meal-ingestion on its dynamics. Regul Pept 2011;167(1):140-148.
  12. *Saito T, Hanai H, Takashima S, Nakagawa E, Okazaki S, Inoue I, Miyata M, Hoshino K, Akashi T, Sasaki M, Goto G, Hayashi M, Itoh M: Neocortical layer formation of human developing brains and lissencephalies: Consideration of layer-specific marker expression. Cereb Cortex 2011;21(3):588-596.
  13. *Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N: Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Med 2011;12:119-126.
  14. *Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimra N: Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep Med 2011;12:127-133.
  15. *Uchimura N, Ogawa A, Hamamura M, Hashimoto T, Nagata H, Uchiyama M: Efficacy and safety of ramelteon in Japanese adults with chronic insomnia:a randomized, double- blind, placebo-controlled study. Expert Rev Neurother 2011;11(2):215-224.
  16. *Kishi T,Fukuo Y,Okochi T,Kitajima T,Kawashima K,Naitoh H,Ujike, H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N: Serotonin 6 reveptor gene is associated with methamphe tamine-induced psychosis in a Japanese population. Drug Alcohol Depend 2011:113(1):1-7.

3. 小児の精神・神経疾患の分子基盤解明と遺伝子治療に関する研究

－著書－

  1. Sugita Y: Angiogenesis of primary brain tumors: The role of Endoglin (CD105). "Molecular targets of CNS Tumors". In:Miklós Garami、 eds. In Tech、 Rijrka、 Croatia、　2011:127-140.

－総説－

  1. *Nishi A, Kuroiwa M, Shuto T: Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons. Front Neuroanat 2011;5:43.
  2. *Shuto T, Nishi A: Treatment of the psychostimulant-sensitized animal model of schizophrenia. CNS Neurosci Ther 2011;17(2):133-139.
  3. Kikuchi K, Kawahara K, Miura N, Ito T, Morimoto Y, Tancharoen S, Takeshige N, Uchikado H, Sakamoto R, Miyagi N, Kikuchi C, Iida N, Shiomi N, Kuramoto T, Hirohata M, Maruyama I, Morioka M, Tanaka E : Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy (Review). Exp Ther Med 2012;4:3-7.
  4. *Nishi Y, Yoh J, Hiejima H and Kojima M.: Structures and molecular forms of ghrelin family peptides.　Peptides (an International Journal) 2011;32(11):2175-2182.

－論文－

  1. *Matsuishi T, Yamashita Y, Takahashi T, Nagamitsu S: Rett syndrome: the state of clinical and basic research、 and future perspectives. Brain Dev 2011;Sep;33(8): 627-631.
  2. *Yamashita Y, Mukasa A, Anai C, Honda Y, Kunisaki C, Koutaki J, Tada Y, Egami C, Kodama N, Nakashima M, Nagamitsu S, Matsuishi T: Summer treatment program for children with attention deficit hyperactivity disorder: Japanese experience in 5 years. Brain Dev 2011;33:260-267.
  3. *Nagamitsu S, Yamashita Y, Ohya T, Shibuya I, Komatsu H, Matsuoka M, Ohzono S, Matsuishi T：Pitfalls in diagnosing psychogenic nonepileptic seizures in a sexually abused child. Brain Dev 2011;33(7):601-603.
  4. *Nagamitsu S, Araki Y, Ioji T, Yamashita F, Ozono S, Kouno M, Iizuka C, Hara M, Shibuya I, Ohya T,Yamashita Y, Tsuda A, Kakuma T, Matsuishi T：Prefrontal brain function in children with anorexia nervosa: A near-infrared spectroscopy study. Brain Dev 2011;33(1):35-44.
  5. *Hara M, Nishi Y, Yamashita Y, Yoh J, Takahashi S, Nagamitsu S, Kakuma T, Hosoda H, Kangawa K, Kojima M, Matsuishi T: Ghrelin levels are reduced in Rett syndrome patients with eating difficulties. Int J Dev Neurosci 2011;29(8):899-902.
  6. *Hara M, Mizuochi T, Kawano G, Koike T, Shibuya I, Ohaya T, Ohbu T, Ohbu K, Nagai K, Nagamitsu S, Yamashita Y, Nakayama T, Matsuishi T: A case clinically mild encephalitis with a reversible lesion (MERS) after mumps vaccination. Brain Dev 2011;33(10):842-824.
  7. *Shibuya I, Nagamitsu S, Okamura H, Komatsu H, Ozono S, Yamashita Y, Matsuishi T: Changes in salivary cortisol levels as a prognostic predictor in children with anorexia nervosa. Int J Psychophysiol 2011;82(2):196-201.
  8. *Watanabe Y, Yano S, Niihori T, Aoki Y, Matsubara Y, Yoshino M, Matsuishi T: A familial case of LEOPARD syndrome associated with a high-functioning autism spectrum disorder. Brain Dev 2011;33:576-579.
  9. *Okamura H, Tsuda A, Matsuishi T: The relationship between perceived loneliness and cortisol awakening responses on work days and weekends. J Psychol Res 2011;53(2):113-120.
  10. *Yamashita Y. Ohya T, Nagamitsu S, Kusukawa J, Hirose S, Matsuishi T: Parageusia in an epileptic child treated with lamotrigine. Pediatri Int　2011;5:1106-1107.
  11. *Ohya T, Yamashita Y, Shibuya I, Hara M, Nagamitsu S, Matsuishi T: Eyelid myoclonia with absences occurring during the clinical course of cryptogenic myoclonic epilepsy of early childhood. Eur J Paediat Neurol 2012 Jul;16(4):399-401.
  12. *Iwata S, Iwata O, Iemura A, Iwasaki M, Matsuishi T: Sleep architecture in healthy 5-year-old preschool children: associations between sleep schedule and quality variables. Acta Paediatr 2012;Mar;101(3):e110-114.
  13. *Iwata O, Iwata S : Filling the evidence gap: How can we improve the outcome of neonatal encephalopathy in the next 10 years? Brain Dev 2011;33(3):221-228.
  14. *Iwata S, Iwata O, Iemura A, Iwasaki M, Matsuishi T: Determinants of sleep patterns in healthy Japanese 5-year-old children. Int J Dev Neurosci 2011;29:57-62.
  15. *Kawano G, Iwata O, Iwata S, Kawano K, Obu K, Kuki I, Rinka H, Shiomi M, Yamanouchi H, Kakuma T, Takashima S, Matsuishi T: Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling. Arch Dis Child 2011;96:936-941.
  16. *Okada J, Iwata S, Hirose A, Kanda H, Yoshino M, Maeno Y, Matsuishi T, Iwata O: Levothyroxine replacement therapy and refractory hypotension out of transitional period in preterm infants. Clin Endocrinol (Oxf) 2011;74:354-364.
  17. *Koga Y, Povalko N, Katayama K, Kakimoto N, Matsuishi T, Naito E, Tanaka M: Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene. Brain Dev 2012;Feb;34(2):87-91.
  18. *Fujimaru C, Okamura H, Kawasaki M, Kakuma T, Yoshii C, Matsuishi T:　Self-perceived Work-related Stress and its Relation to Salivary lgA、 Cortisol and 3-Methoxy- 4-hydroxyphenyl Glycol Levels among Neonatal Intensive Care Nurses. Stress Health 2012;28(2):171-174.
  19. *Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T: Alterations of Gene Expression and Glutamate Clearance in Astrocytes Derived from an MeCP2-null Mouse Model of Rett Syndrome. PloS ONE 2012;7(4):e35354
  20. *Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y, Sakamoto T, Kosai K: Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: A novel antiangiogenic therapy. Biochem Biophys Res Commun 2011;16;413(1):128-135.
  21. *Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K: Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses (CRA) -Implications for the generation of ideal m-CRAs. Cancer Gene Ther 2011;18(10):724-733.
  22. *Fotovati A, Abu-Ali S, Wang P-S, Deleyrolle LP, Lee C, Triscott J, Chen JY, Franciosi S, Nakamura Y, Sugita Y, Uchiumi T, Kuwano M, Leavitt BR, Singh SK, Jury A, Jones C, Wakimoto H, Reynolds BA, Pallen CJ, Dunn S:YB-1 bridges neuronal stem cells and brain tumor-imitiating cells via its roles in differentiation and cell growth. Cancer Res 2011;71:5569-15578.
  23. *Fotovati A, Abu-Ali S, Sugita Y, Nakamura Y: Expression of N-myc downstream regulated gene 1(NDRG1) in central neurocytoma. J Clin Neurosci 2011;18:1383-1385.
  24. *Sugita Y: Left cerebellar hemispheric tumor in a 80-year old man. 　Neuropathol 2011;31:556-559.
  25. *Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, Ushikubi F, Kitaoka S, Aoki T, Inoue H, Matsuoka T, Narumiya S: Thromboxane receptor activation enhances striatal dopamine release、 leading to suppression of GABAergic transmission and enhanced sugar intake. Eur J Neurosci 2011;Aug;34(4):594-604.
  26. *Kuroiwa M, Snyder GL, Shuto T, Fukuda A, Yanagawa Y, Benavides DR, Nairn AC, Bibb JA, Greengard P, Nishi A: Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl) 2012 Feb;219(4):1065-1079.
  27. *Cui H, Mason BL, Lee C, Nishi A, Elmquist JK, Lutter M: Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiol Behav 2012;15;106(2):201-210.
  28. *Hirose Y, Kaida H, Ishibashi M, Kawahara A, Kobayashi M, Hayabuchi N：　Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.　Jpn J Radiol 2011;29:111-118.
  29. *Kaida H, Hiromatsu Y, Kurata S, Kawahara A, Hattori S, Taira T, Kobayashi M, Uchida M, Yamada K, Mihashi H, Umeno H, Kage M, Nakashima T, Hayabuchi N, Ishibashi M：Relationship between clinicopathological factors and　fluorine-18-　fluorodeoxyglucose uptake in patients with papillary thyroid cancer. Nucl Med Commun 2011;32:690-698.
  30. *Kurata S, Shizukuishi K, Tateishi U, Yoneyama T, Hino A, Ishibashi M, Inoue T：Age-related changes in pre- and postmenopausal women investigated with (18 )F-fluoride PET- a preliminary study.　Skeletal Radiol 2012 Aug;41(8):947-953.
  31. *Yano S, Baskin B, Bagheri A, Watanabe Y, Moseley K, Nishimura A, Matsumoto N, Ray P: Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosomeinactivation and clinical phenotypes in two female individuals with GPC3 mutations. Clin Genet 2011; Nov;80(5):466-471.
  32. *Tahara N, Yamagishi S, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Mohar D, Ishibashi M, Hayabuchi N,I maizumi T：Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis 2011;219(1):311-315.
  33. *Mizoguchi M, Tahara N, Tahara A Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T：Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective,randomized,comparator- controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta　JACC Cardiovasc Imaging 2011;4:1110-1118.
  34. *Abe T, Hagiwara N, Hirohata M, Uchiyama Y, Tanaka N, Hayabuchi N: Partially thrombosed vertebral artery aneurysm with wall enhancement treated by stent-assisted coil embolization. Neurol Med Chir (Tokyo) 2011;51(6):431-433.
  35. *Abe T, Uchiyama Y, Tanaka N, Hayabuchi N: Radiation dose measurement with newly developed phantom for interventional neuroradiology. NRJ Digital-The neuroradiology journal 2011;1(20):969-971.
  36. *Segawa Y, Matsufuji M, Itokazu N, Utsunomiya H, Watanabe Y, Yoshino M, Takashima S: A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations. Brain Dev 2011;33:45-48.
  37. *Wang W, Takashima S, Segawa Y, Itoh M, Shi X, Hwang S, Nabeshima K, Takeshita M, Hirose S: The developmental changes of Nav1.1 and Nav1.2 expression in the human hippocampus and temporal lobe. Brain Res 2011;1389:61-70.
  38. *Saito T, Hanai H, Takashima S, Nakagawa E, Okazaki S, Inoue I, Miyata M, Hoshino K, Akashi T, Sasaki M, Goto G, Hayashi M、 Itoh M: Neocortical Layer Formation of Human Developing Brains and Lissencephalies: Consideration of Layer-Specific Marker Expression. Cereb Cortex 2011;21:588-596.
  39. *Holland JM, Thompson LW, Cucciare MA, Tsuda A, Okamura H, Spiegel D, Rasgon NL, Gallagher-Thompson D: Cortisol outcomes among Caucasian and latina/Hispanic women caring for a family member with dementia. Sress and Health、 published online in Wiley Online Library 2011;27:335-346.
  40. *Okamura H, Tsuda A, Matsuishi T: The relationship between perceived loneliness and cortisol awakening responses on work days and weekends. Japanese Psychological Research 2011;53:113-120.
  41. *Horiuchi S, Tsuda A, Kobayashi H, Prochaska JM: Reliability and validity of the Japanese language version of Pro-Change's decisional balance measure for effective stress management. Japanese Psychological Research 2011;54:128-136.
  42. *Matsufuji M, Utsunomiya H, Inoue T, Yasumoto S, Takashima S, Mitsudome A: Magnetic resonance imaging volumetry and clinical analysis of epilepsy patients with unilateral hippocampal abnormalities. Pediatr Int 2011;54:19-26.